{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T13:33:25Z","timestamp":1778679205971,"version":"3.51.4"},"reference-count":61,"publisher":"FapUNIFESP (SciELO)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq Bras Endocrinol Metab"],"published-print":{"date-parts":[[2006,8]]},"abstract":"<jats:p>Osteoporosis is a worldwide problem that results in fractures that lead to disability and high costs to society. Estrogen therapy is frequently utilized for postmenopausal symptoms, but also has proven protective effects on the skeleton. The main action of estrogen at the cellular level is to inhibit the osteoclast by increasing levels of osteoprotegerin (OPG). OPG binds to the receptor activator of NFkB and prevents osteoclast differentiation, activity and survival. Numerous trials have demonstrated the positive effect estrogen has on the improvement of bone mineral density, and lower doses have also proven efficacious with fewer side effects. Both observational and randomized clinical trials have demonstrated the ability of estrogen treatment to prevent fractures. Topics that remain controversial include the appropriate length of estrogen treatment for postmenopausal women and the appropriate follow-up after treatment discontinuation.<\/jats:p>","DOI":"10.1590\/s0004-27302006000400016","type":"journal-article","created":{"date-parts":[[2006,12,12]],"date-time":"2006-12-12T17:30:21Z","timestamp":1165944621000},"page":"705-719","source":"Crossref","is-referenced-by-count":45,"title":["Estrogen therapy for postmenopausal osteoporosis"],"prefix":"10.1590","volume":"50","author":[{"given":"Lorraine A.","family":"Fitzpatrick","sequence":"first","affiliation":[{"name":"Amgen, Inc.,  USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","series-title":"EpiSource"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00198-004-1627-0","article-title":"An estimate of the worldwide prevalence, mortality and disability associated with hip fracture","volume":"15","author":"Johnell O","year":"2004","journal-title":"Osteoporos Int","ISSN":"https:\/\/id.crossref.org\/issn\/0937-941X","issn-type":"print"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s00198-005-1993-2","article-title":"Fragility fracture-related direct medical costs in the first year following a nonvertebral fracture in a managed care setting","volume":"17","author":"Ohsfeldt RL","year":"2006","journal-title":"Osteoporos Int","ISSN":"https:\/\/id.crossref.org\/issn\/0937-941X","issn-type":"print"},{"key":"ref4","series-title":"US Surgeon General's Report"},{"issue":"9319","key":"ref5","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(02)08657-9","article-title":"Epidemiology and outcomes of osteoporotic fractures","volume":"359","author":"Cummings SR","year":"2002","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"issue":"12B","key":"ref6","doi-asserted-by":"crossref","first-page":"74S","DOI":"10.1016\/j.amjmed.2005.09.035","article-title":"Vasomotor symptom relief versus unwanted effects: role of estrogen dosage","volume":"118","author":"Ettinger B","year":"2005","journal-title":"Am J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0002-9343","issn-type":"print"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/424389a","article-title":"Endocrinology: bone adaptation requires oestrogen receptor-alpha","volume":"424","author":"Lee K","year":"2003","journal-title":"Nature","ISSN":"https:\/\/id.crossref.org\/issn\/0028-0836","issn-type":"print"},{"issue":"5","key":"ref8","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1210\/jc.2004-2168","article-title":"Review: Estrogen receptor-related receptor a: a mediator of estrogen response in bone","volume":"90","author":"Bonnelye E","year":"2005","journal-title":"J Clin Endocrinol Metab","ISSN":"https:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1210\/edrv.20.3.0367","article-title":"Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families","volume":"20","author":"Suda T","year":"2005","journal-title":"Endocr Rev","ISSN":"https:\/\/id.crossref.org\/issn\/0163-769X","issn-type":"print"},{"issue":"12","key":"ref10","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1172\/JCI27071","article-title":"Pathogenesis of osteoporosis: concepts, conflicts, and prospects","volume":"115","author":"Raisz Lawrence G","year":"2005","journal-title":"J Clin Invest","ISSN":"https:\/\/id.crossref.org\/issn\/0021-9738","issn-type":"print"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1101\/gad.12.9.1260","article-title":"Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification","volume":"12","author":"Bucay N","year":"1998","journal-title":"Genes Dev","ISSN":"https:\/\/id.crossref.org\/issn\/0890-9369","issn-type":"print"},{"issue":"8","key":"ref12","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1172\/JCI200317215","article-title":"Role of RANK ligand in mediating increased bone resorption in early postmenopausal women","volume":"111","author":"Eghbali-Fatourechi G","year":"2003","journal-title":"J Clin Invest","ISSN":"https:\/\/id.crossref.org\/issn\/0021-9738","issn-type":"print"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1056\/NEJM199410203311604","article-title":"Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man","volume":"331","author":"Smith EP","year":"1994","journal-title":"N Engl J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref14","first-page":"3689","article-title":"Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens","volume":"80","author":"Morishima A","year":"1995","journal-title":"J Clin Endocrinol Metab","ISSN":"https:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1056\/NEJM199707103370204","article-title":"Effect of testosterone and estradiol in a man with aromatase deficiency","volume":"337","author":"Carani C","year":"1997","journal-title":"N Engl J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"issue":"17","key":"ref16","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1001\/jama.292.17.2105","article-title":"Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes","volume":"292","author":"Ioannidis JPA","year":"2004","journal-title":"JAMA","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"issue":"12","key":"ref17","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1172\/JCI10942","article-title":"Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men","volume":"106","author":"Falahati-Nini A","year":"2000","journal-title":"J Clin Invest","ISSN":"https:\/\/id.crossref.org\/issn\/0021-9738","issn-type":"print"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJM198411153112002","article-title":"Relative contributions of aging and estrogen deficiency to postmenopausal bone loss","volume":"311","author":"Richelson LS","year":"1984","journal-title":"N Engl J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0889-857X(05)70191-5","article-title":"Role of estrogens in the management of postmenopausal bone loss","volume":"27","author":"Gallagher JC","year":"2001","journal-title":"Rheum Dis Clin North Am","ISSN":"https:\/\/id.crossref.org\/issn\/0889-857X","issn-type":"print"},{"key":"ref20","first-page":"2239","article-title":"Associations between low levels of serum estradiol, bone density, and fractures among elderly women: The study of osteoporotic fractures","volume":"83","author":"Ettinger B","year":"1998","journal-title":"J Clin Endocrinol Metab","ISSN":"https:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"issue":"10","key":"ref21","doi-asserted-by":"crossref","first-page":"4954","DOI":"10.1210\/jc.2004-0434","article-title":"Endogenous levels of serum estradiol and sex hormone binding globulin determine bone mineral density, bone remodeling, the rate of bone loss, and response to treatment with estrogen in elderly women","volume":"89","author":"Rapuri JPB","year":"2004","journal-title":"J Clin Endocrinol Metab","ISSN":"https:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.7326\/0003-4819-122-1-199501010-00002","article-title":"Estrogen replacement therapy and fractures in older women: Study of Osteoporotic Fracture Research Group","volume":"122","author":"Cauley JA","year":"1995","journal-title":"Ann Intern Med","ISSN":"https:\/\/id.crossref.org\/issn\/0003-4819","issn-type":"print"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1001\/jama.1996.03540170033029","article-title":"Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen\/progestin interventions (PEPI) trial: The writing group for the PEPI","volume":"276","year":"1996","journal-title":"JAMA","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the women's health initiative randomized controlled trial","volume":"288","year":"2002","journal-title":"JAMA","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"issue":"13","key":"ref25","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.290.13.1729","article-title":"Effects of estrogen plus progestin on risk of fracture and bone mineral density: the women's health initiative randomized trial","volume":"290","author":"Cauley JA","year":"2003","journal-title":"JAMA","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"issue":"14","key":"ref26","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy","volume":"291","year":"2004","journal-title":"JAMA","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomized trial of effect of alendronate on risk of fracture in women with existing vertebral fractures","volume":"348","author":"Black DM","year":"1996","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.282.14.1344","article-title":"Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial","volume":"282","author":"Harris ST","year":"1999","journal-title":"JAMA","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJM200102013440503","article-title":"Effect of risedronate on the risk of hip fracture in elderly women","volume":"344","author":"McClung MR","year":"2001","journal-title":"N Engl J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1001\/jama.280.24.2077","article-title":"Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the fracture intervention trial","volume":"280","author":"Cummings SR","year":"1998","journal-title":"JAMA","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1080\/cmt.6.4.302.313","article-title":"Risks of estrogen plus progestin therapy: a sensitivity analysis of findings in the Women's Health Initiative randomized controlled trial","volume":"6","author":"Shapiro S","year":"2003","journal-title":"Climacteric","ISSN":"https:\/\/id.crossref.org\/issn\/1369-7137","issn-type":"print"},{"issue":"6","key":"ref32","first-page":"1225","article-title":"Effect of the Women's Health Initiative on Women's Decisions to Discontinue Postmenopausal Hormone Therapy","volume":"102","author":"Ettinger B","year":"2003","journal-title":"Obstet Gynecol","ISSN":"https:\/\/id.crossref.org\/issn\/0029-7844","issn-type":"print"},{"issue":"18","key":"ref33","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1001\/jama.291.18.2212","article-title":"Fracture incidence in relation to the pattern of use of hormone therapy in postmenopausal women","volume":"291","author":"Banks E","year":"2004","journal-title":"JAMA","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"issue":"4","key":"ref34","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1210\/er.2001-5002","article-title":"Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women","volume":"23","author":"Wells G","year":"2002","journal-title":"Endocr Rev","ISSN":"https:\/\/id.crossref.org\/issn\/0163-769X","issn-type":"print"},{"key":"ref35","series-title":"Consensus Development Conference on Osteoporosis"},{"issue":"4","key":"ref36","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJMoa022464","article-title":"Bone loss and bone size after menopause","volume":"349","author":"Ahlborg HG","year":"2003","journal-title":"N Engl J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"issue":"9","key":"ref37","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1359\/JBMR.050508","article-title":"Effect of hormone replacement, alendronate, or combination therapy on hip structural geometry: A 3-year, double-blind, placebo-controlled clinical trial","volume":"20","author":"Greenspan SL","year":"2005","journal-title":"J Bone Miner Res","ISSN":"https:\/\/id.crossref.org\/issn\/0884-0431","issn-type":"print"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1001\/jama.290.8.1042","article-title":"Ultralow-dose micronized 17-beta estradiol and bone density and bone metabolism in older women: a randomized controlled trial","volume":"290","author":"Prestwood KM","year":"2003","journal-title":"JAMA","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"issue":"1","key":"ref39","doi-asserted-by":"crossref","first-page":"40","DOI":"10.7326\/0003-4819-106-1-40","article-title":"Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium","volume":"106","author":"Ettinger B","year":"1987","journal-title":"Ann Intern Med","ISSN":"https:\/\/id.crossref.org\/issn\/0003-4819","issn-type":"print"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s00198-004-1773-4","article-title":"Bone response to treatment with lower doses of conjugated estrogens with and without medroxyprogesterone acetate in early postmenopausal women","volume":"16","author":"Lindsay R","year":"2005","journal-title":"Osteoporos Int","ISSN":"https:\/\/id.crossref.org\/issn\/0937-941X","issn-type":"print"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"897","DOI":"10.7326\/0003-4819-130-11-199906010-00005","article-title":"The effect of low-dose continuous estrogen and progesterone therapy with calcium and vitamin D on bone in elderly women: A randomized, controlled trial","volume":"130","author":"Recker RR","year":"1999","journal-title":"Ann Intern Med","ISSN":"https:\/\/id.crossref.org\/issn\/0003-4819","issn-type":"print"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.maturitas.2004.03.016","article-title":"Levonorgestrel and 17b-estradiol given transdermally for the prevention of postmenopausal osteoporosis","volume":"50","author":"Warming L","year":"2005","journal-title":"Maturitas","ISSN":"https:\/\/id.crossref.org\/issn\/0378-5122","issn-type":"print"},{"issue":"3","key":"ref43","first-page":"330","article-title":"A randomized controlled trial of four doses of transdermal estradiol for preventing postmenopausal bone loss","volume":"94","author":"Weiss SR","year":"1999","journal-title":"Obstet Gynecol","ISSN":"https:\/\/id.crossref.org\/issn\/0029-7844","issn-type":"print"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1001\/archinte.1997.00440430091011","article-title":"Low-dose esterified estrogen therapy: effects on bone, plasma estradiol concentrations, endometrium, and lipid levels. Estratab\/Osteoporosis Study Group","volume":"157","author":"Genant HK","year":"1997","journal-title":"Arch Intern Med","ISSN":"https:\/\/id.crossref.org\/issn\/0003-9926","issn-type":"print"},{"issue":"2","key":"ref45","first-page":"205","article-title":"Low-dosage esterified estrogens opposed by progestin at 6-month intervals","volume":"98","author":"Ettinger B","year":"2001","journal-title":"Obstet Gynecol","ISSN":"https:\/\/id.crossref.org\/issn\/0029-7844","issn-type":"print"},{"key":"ref46","first-page":"720","article-title":"Alendronate and estrogen effects in postmenopausal women with low bone mineral density","volume":"85","author":"Bone HG","year":"2000","journal-title":"J Clin Endocrinol Metab","ISSN":"https:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"issue":"19","key":"ref47","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1001\/jama.289.19.2525","article-title":"Combination therapy with hormone replacement and alendronate for prevention of bone loss in elderly women: A randomized controlled trial","volume":"289","author":"Greenspan SL","year":"2003","journal-title":"JAMA","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"issue":"5","key":"ref48","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1359\/jbmr.2001.16.5.925","article-title":"Parathyroid hormone added to established hormone therapy: Effects on vertebral fracture and maintenance of bone mass after parathyroid hormone withdrawal","volume":"16","author":"Cosman F","year":"2001","journal-title":"J Bone Miner Res","ISSN":"https:\/\/id.crossref.org\/issn\/0884-0431","issn-type":"print"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0140-6736(97)02342-8","article-title":"Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis","volume":"350","author":"Lindsay R","year":"1997","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1210\/jcem.87.4.8415","article-title":"Changes in bone density and turnover explain the reductions in incidence of non-vertebral fractures that occur during treatment with antiresorptive agents","volume":"87","author":"Hochberg MC","year":"2002","journal-title":"J Clin Endocrinol Metab","ISSN":"https:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"issue":"3","key":"ref51","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004143.pub2","article-title":"The Cochrane Database of Systematic Reviews: Long term hormone therapy for perimenopausal and postmenopausal women","author":"Farquhar CM","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1001\/archinte.160.20.3065","article-title":"How many women lose bone mineral density while taking hormone replacement therapy?: Results from the postmenopausal estrogen\/progestin interventions trial","volume":"160","author":"Greendale GA","year":"2000","journal-title":"Arch Intern Med","ISSN":"https:\/\/id.crossref.org\/issn\/0003-9926","issn-type":"print"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/S0140-6736(78)92402-9","article-title":"Bone response to termination of estrogen treatment","volume":"1","author":"Lindsay R","year":"1978","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1007\/s001980050096","article-title":"Variation in the efficacy of hormone replacement therapy in the prevention of hip fracture: Swedish Hip Fracture Study Group","volume":"8","author":"Michaelsson K","year":"1998","journal-title":"Osteoporos Int","ISSN":"https:\/\/id.crossref.org\/issn\/0937-941X","issn-type":"print"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"5700","DOI":"10.1210\/jcem.86.12.8079","article-title":"Timing of estrogen replacement therapy for optimal osteoporosis prevention","volume":"86","author":"Cauley JA","year":"2001","journal-title":"J Clin Endocrinol Metab","ISSN":"https:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S8756-3282(03)00171-6","article-title":"Effect of withdrawal of hormone replacement therapy on bone mass and bone turnover: the OFELY study","volume":"33","author":"Sornay-Rendu E","year":"2003","journal-title":"Bone","ISSN":"https:\/\/id.crossref.org\/issn\/8756-3282","issn-type":"print"},{"issue":"6","key":"ref57","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1097\/01.GME.0000123641.76105.B5","article-title":"Changes in bone density and turnover after alendronate or estrogen withdrawal","volume":"11","author":"Wasnich RD","year":"2004","journal-title":"Menopause","ISSN":"https:\/\/id.crossref.org\/issn\/1072-3714","issn-type":"print"},{"issue":"11","key":"ref58","doi-asserted-by":"crossref","first-page":"4914","DOI":"10.1210\/jc.2002-020727","article-title":"Effect of discontinuation of estrogen, calcitriol, and the combination of both on bone density and bone markers","volume":"87","author":"Gallagher JC","year":"2002","journal-title":"J Clin Endocrinol Metab","ISSN":"https:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1001\/archinte.162.6.665","article-title":"Bone mass response to discontinuation of long-term hormone replacement therapy: Results from the postmenopausal estrogen\/progestin interventions (PEPI) safety follow-up study","volume":"162","author":"Greendale GA","year":"2002","journal-title":"Arch Intern Med","ISSN":"https:\/\/id.crossref.org\/issn\/0003-9926","issn-type":"print"},{"issue":"11","key":"ref60","doi-asserted-by":"crossref","first-page":"875","DOI":"10.7326\/0003-4819-137-11-200212030-00008","article-title":"Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis: A randomized, double-blind, placebo-controlled trial","volume":"137","author":"Greenspan SL","year":"2002","journal-title":"Ann Intern Med","ISSN":"https:\/\/id.crossref.org\/issn\/0003-4819","issn-type":"print"},{"issue":"7","key":"ref61","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1001\/jama.288.7.872","article-title":"Postmenopausal hormone replacement therapy: Scientific review","volume":"288","author":"Nelson HD","year":"2002","journal-title":"JAMA","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"}],"container-title":["Arquivos Brasileiros de Endocrinologia &amp; Metabologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/abem\/v50n4\/31872.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T15:54:05Z","timestamp":1495727645000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-27302006000400016&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":61,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S0004-27302006000400016"],"URL":"https:\/\/doi.org\/10.1590\/s0004-27302006000400016","relation":{},"ISSN":["0004-2730"],"issn-type":[{"value":"0004-2730","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}